PRESS RELEASE published on 06/17/2024 at 08:00, 3 months 2 days ago DEFENCE’S CHIEF SCIENTIFIC OFFICER DR. MOUTIH RAFEI DISCUSSES THE ACCUM PLATFORM FOR CANCER TREATMENTS ON MONEY TALK RADIO WITH ELLIS MARTIN Defence Therapeutics Inc.'s Chief Scientific Officer Dr. Moutih Rafei discusses the ACCUM platform for cancer treatments on Money Talk Radio with Ellis Martin Defence Therapeutics Inc. Cancer Treatments ACCUM Platform Dr. Moutih Rafei Money Talk Radio
BRIEF published on 06/10/2024 at 08:05, 3 months 9 days ago Defence Therapeutics participera au congrès annuel 2024 du SNMMI à Toronto Thérapeutique De Défense SNMMI AccuTRIC™ Médecine Nucléaire Imagerie Moléculaire
BRIEF published on 06/10/2024 at 08:05, 3 months 9 days ago Defence Therapeutics to Attend 2024 SNMMI Annual Meeting in Toronto Defence Therapeutics Nuclear Medicine SNMMI AccuTRIC™ Molecular Imaging
PRESS RELEASE published on 06/10/2024 at 08:00, 3 months 9 days ago DEFENCE TO PARTICIPATE TO 2024 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING IN TORONTO ON JUNE 11, 2024 Defence Therapeutics Inc. to participate in the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024, presenting their novel Radio-Immuno-Conjugate (RIC) for cancer treatment Cancer Treatment Defence Therapeutics Inc. Molecular Imaging Society Of Nuclear Medicine Radio-Immuno-Conjugate
BRIEF published on 06/06/2024 at 08:05, 3 months 13 days ago L'étude AccuTOX de Defense Therapeutics publiée dans le Journal of Translational Medicine Immunothérapie Essais Cliniques Thérapeutique De Défense AccuTOX Anti-cancer
BRIEF published on 06/06/2024 at 08:05, 3 months 13 days ago Defence Therapeutics' AccuTOX Study Published in Journal of Translational Medicine Clinical Trials Immunotherapy Defence Therapeutics AccuTOX Anti-cancer
PRESS RELEASE published on 06/06/2024 at 08:00, 3 months 13 days ago DEFENCE’S ACCUTOX PUBLISHED IN THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE ITS PEER STUDY WITH PRECLINICAL DATA ON ACCUTOX AS AN ANTI-CANCER MOLECULE Defence Therapeutics Inc.'s AccuTOX published in the prestigious Journal of Translational Medicine along with preclinical data on AccuTOX as an anti-cancer molecule. Study highlights AccuTOX's superior therapeutic properties and versatility for different cancer treatments Preclinical Data Defence Therapeutics Inc. AccuTOX Journal Of Translational Medicine Anti-cancer Molecule
BRIEF published on 05/14/2024 at 08:05, 4 months 5 days ago Defence Therapeutics étend son portefeuille de brevets à l'échelle mondiale Thérapeutique De Défense Délivrance De Brevet Innovation Dans Les Soins De Santé Vaccin Immuno-oncologique Système De Délivrance De Médicaments
BRIEF published on 05/14/2024 at 08:05, 4 months 5 days ago Defence Therapeutics Expands Patent Portfolio Globally Defence Therapeutics Patent Issuance Drug Delivery System Innovation In Healthcare Immune-Oncology Vaccine
PRESS RELEASE published on 05/14/2024 at 08:00, 4 months 5 days ago DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT PROTECTION ON KEY TECHNOLOGIES Defence Therapeutics strengthens and expands global patent protection on key technologies, including vaccine enhancer platform and ADC platform technology. The new patents and allowances showcase the company's commitment to innovation in biopharmaceuticals Biopharmaceuticals Defence Therapeutics Patent Protection Vaccine Enhancer ADC Platform Technology
Published on 09/20/2024 at 02:00, 1 hour 6 minutes ago Academy of Math and Science Celebrates Hispanic Heritage Month
Published on 09/19/2024 at 23:15, 3 hours 51 minutes ago Cypher Metaverse Inc. Announces Second Closing of Financing
Published on 09/19/2024 at 23:00, 4 hours 6 minutes ago WestJet Partners with FLYHT and NOAA to Improve Weather Forecasting in North America
Published on 09/19/2024 at 23:00, 4 hours 6 minutes ago Cerrado Files NI 43-101 Preliminary Economic Assessment Technical Report and Mineral Resource Estimate for The Minera Don Nicolas Mine in Santa Cruz, Argentina
Published on 09/19/2024 at 21:09, 5 hours 56 minutes ago EQS-Adhoc: Mercedes-Benz Group AG adjusts full-year guidance for the year 2024 based on current market outlook
Published on 09/19/2024 at 18:44, 8 hours 22 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/19/2024 at 18:03, 9 hours 3 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 09/19/2024 at 17:52, 9 hours 14 minutes ago PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Published on 09/19/2024 at 17:52, 9 hours 14 minutes ago PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros
Published on 09/19/2024 at 17:45, 9 hours 21 minutes ago Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Published on 09/19/2024 at 17:45, 9 hours 21 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Published on 09/19/2024 at 17:45, 9 hours 21 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)